Post-approval studies (Phase 4)Study completedNCT03781089
What this trial is testing
Patiromer Efficacy to Reduce Episodic Hyperkalemia in End Stage Renal Disease Patients
Who this might be right for
HyperkalemiaEnd Stage Renal Disease
Duke University 36